---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-008275"
form_type: "8-K"
ticker: "GCTK"
cik: "0001506983"
company_name: "Glucotrack, Inc."
filed_at: "2025-02-26T23:59:59+00:00"
generated_at: "2026-05-26T03:30:48.911936+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Glucotrack appoints diabetes expert Dr. Guillermo Umpierrez to Medical Advisory Board

## Summary
- Dr. Umpierrez, Professor of Medicine at Emory and past ADA president for Medicine & Science, joins effective immediately.
- He will provide strategic guidance as Glucotrack advances its long-term implantable CBGM system through clinical development.
- Glucotrack's CBGM has 3-year sensor life, no wearable component, and measures blood glucose directly to reduce lag time.
- CEO Paul Goode cites Dr. Umpierrez's clinical and research expertise as valuable for upcoming human trials.

## SEC filing metadata
- accession: 0001493152-25-008275
- form_type: 8-K
- ticker: GCTK
- cik: 0001506983
- company_name: Glucotrack, Inc.
- filed_at: 2025-02-26T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506983/000149315225008275/0001493152-25-008275-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506983/000149315225008275/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-008275
- JSON: https://secwatch.observer/filing/0001493152-25-008275.json
- Plain text: https://secwatch.observer/filing/0001493152-25-008275.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.